5WA5

Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor XMD11-50

Functional Information from PDB Data

site_id	AC1
Number of Residues	9
Details	binding site for residue 4K4 A 201

Chain	Residue
A	TRP81
A	PRO82
A	LEU94
A	GLU115
A	ASN116
A	ASN140
A	ILE146
A	HOH324
A	HOH367

---

site_id	AC2
Number of Residues	7
Details	binding site for residue EDO A 202

Chain	Residue
A	ILE100
A	ILE101
A	LYS102
A	THR103
A	ASN135
A	HOH321
A	HOH328

---

site_id	AC3
Number of Residues	5
Details	binding site for residue EDO A 203

Chain	Residue
A	SER51
A	ASN52
A	LYS57
A	TYR118
A	HOH327

---

Functional Information from PROSITE/UniProt

site_id	PS00633
Number of Residues	60
Details	BROMODOMAIN_1 Bromodomain signature. AwpFqqpvDavklnlpDYYkiIktpMdmgtIkkrlenny..Ywnaqeciqdfnt.MftNCyiY

Chain	Residue	Details
A	ALA80-TYR139

---

Functional Information from SwissProt/UniProt

site_id	SWS_FT_FI1
Number of Residues	1
Details	SITE: Acetylated histone binding => ECO:0000269|PubMed:22464331

Chain	Residue	Details
A	ASN140

---

site_id	SWS_FT_FI2
Number of Residues	2
Details	CROSSLNK: Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733

Chain	Residue	Details
A	LYS99

---